NCT05110300

Brief Summary

ZeroG is an FDA-listed robotic body weight support system (BWSS). Mounted on an overhead track, patients are fitted in a harness system tethered to said track, and are able to practice gait and balance activities without the risk of falling. This compensates for ineffective postural control permitting intensive therapy sessions earlier in recovery. The purpose of this study is to determine if inducing effective and safe balance perturbations during standing and walking in the BWSS more effectively improve postural control than the BWSS without perturbations. The target population are those patients in the post-acute phase of stroke admitted for inpatient rehabilitation of balance impairments. Site investigators and/or research staff will obtain names of potential subjects from internal reporting identifying inpatients who may qualify for the study based on the inclusion criteria. Trained site investigators will meet with potential subjects to explain the study, complete a screening interview for exclusion and inclusion criteria, answer any questions, obtain informed consent and HIPAA authorization, and schedule the study therapy sessions involving the protocol. Based on the randomization scheme provided by the lead site, consented subjects will be randomized to either the BWSS with perturbations (BWSS-P) or standard BWSS control without perturbations. Subjects will perform 2 to 6 sessions in their designated intervention using a structured protocol for each session. To compare differences between treatment groups, outcome measures will be collected at baseline before any BWSS sessions are performed and within 48 hours after completing the final treatment session.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

4 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 5, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

December 15, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 6, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 6, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

April 8, 2025

Completed
Last Updated

November 14, 2025

Status Verified

November 1, 2024

Enrollment Period

1.9 years

First QC Date

October 8, 2021

Results QC Date

November 6, 2024

Last Update Submit

November 10, 2025

Conditions

Keywords

Stroke RehabilitationNeurological RehabilitationGait and AmbulationBalance ImpairmentPostural Balance ImpairmentPostural Balance PerturbationGait PerturbationBody Weight Support SystemActivities of Daily LivingOccupational TherapyPhysical TherapyLong-term Acute Care HospitalInpatient Rehabilitation FacilityBerg Balance ScaleActivity specific balance confidence scale10 meter walk test

Outcome Measures

Primary Outcomes (3)

  • Berg Balance Scale Pre-intervention Assessment Scores

    The Berg Balance Scale is a standardized objective measure of a subject/participant's balance. It is scored on a scale of 0 to 56, with 56 being the best score possible.

    Baseline (within 72 hours of admission)

  • Berg Balance Scale Post-intervention Assessment Scores

    The Berg Balance Scale is a standardized objective measure of a subject/participant's balance. It is scored on a scale of 0 to 56, with 56 being the best score possible.

    The post-assessment BBS will be collected within 48 hours of the last study session or discharge from the health system, on average, 17 days.

  • Difference in Berg Balance Scale Pre-Intervention and Post-Intervention Assessment Scores

    The Berg Balance Scale is a standardized objective measure of a subject/participant's balance. It is scored on a scale of 0 to 56, with 56 being the best score possible. Admission and discharge Berg scores are collected from a chart review within 48 hours of participant discharge. The change in Berg score is calculated by subtracting the participants admission or pre-assessment score from their discharge or post-assessment score: (Post assessment)-(Pre assessment)

    The baseline pre-assessment BBS score will be collected within 72 hours of admission, as part of their normal care. The post-assessment will be collected within 48 hours of the last study session or discharge from the health system, on average, 17 days.

Secondary Outcomes (12)

  • Activities Specific Balance Scale (ABC) Pre-intervention Scores

    The pre-assessment ABC Scale will be collected within 48 hours of the first study session.

  • Activities Specific Balance Scale (ABC) Post-intervention Scores

    The post-assessment ABC Scale will be collected within 48 hours of the last study session or discharge from the health system, on average, 17 days.

  • Difference in Activities-Specific Balance Confidence (ABC) Scale Score Change

    The pre-assessment ABC Scale will be conducted within 48 hours prior to the first study session. The post-assessment ABC scale will be collected within 48 hours of the last study session or discharge from the health system, on average, 17 days.

  • 10 Meter Walk Test (10MWT) Pre-intervention Scores

    The pre-assessment 10MWT will be conducted by site investigators within 48 hours prior to the first study session.

  • 10 Meter Walk Test (10MWT) Post-intervention Scores

    The post-assessment 10MWT will be collected within 48 hours of the last study session or discharge from the health system, on average, 17 days.

  • +7 more secondary outcomes

Study Arms (2)

Body weight support system control group

ACTIVE COMPARATOR

The Body weight support system (BWSS) active comparator control group will conduct 2 to 6, 30 minute sessions, over two-weeks. To be as pragmatic and clinically relevant as possible, treatment sessions will be incorporated directly to the participants' normal care. Furthermore, participants are allowed to complete 2 to 6 sessions as dictated by short or unexpected changes to the discharge planning timeline. During each session, participants will conduct balance exercises, including: marching, side-stepping, retro-ambulation, step-taps, and step-ups. Participants will also conduct various standard gait exercises, including: ambulation over the ground, going up and down stairs, and performing sit-to-stand transitions.

Device: Body weight support system control group

Body weight support system with balance perturbations

EXPERIMENTAL

The BWSS with balance perturbations (BWSS-P) experimental intervention group will also conduct 2 to 6, 30 minute sessions, over two-weeks. Participants in the BWSS-P group will conduct the same balance and gait exercises as the control group, including: marching, side-stepping, retro-ambulation, step-taps, step-ups, ambulation over the ground, going up and down stairs, and performing sit-to-stand transitions. However, each sessions will include eight, resistive or assistive, balance perturbations, two in each cardinal direction (lateral, anterior, and posterior).

Device: Body weight support system with balance perturbations

Interventions

Participants will complete the physical therapy exercises as described previously, without experiencing, therapist induced, balance perturbations.

Also known as: ZeroG, BWSS, BWSS control, Zero G
Body weight support system control group

Participants will complete the physical therapy exercises as described previously, while experiencing intermittent, therapist induced, balance perturbations aimed at training the participant's balance-control and balance-reactions. With the ZeroG BWSS integrated TRiP module, therapist's are able to induce safe lateral, anterior, or posterior perturbations via a Wi-Fi-enabled handheld device. The force, or level, of perturbation can be adjusted from 1 (least amount of force) up to 10 (highest amount of force) using the same handheld device,

Also known as: ZeroG with training response in postural rehabilitation, ZeroG - TriP, ZeroG TriP, BWSS-P, BWSS+P, Zero G TRiP, Zero G - TRiP, TRiP
Body weight support system with balance perturbations

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admitted to one of the listed study locations for inpatient rehabilitation following a stroke.
  • Be 18 years of age or older.
  • Have at least a moderate fall risk or better, shown by an admission Berg Balance Scale (BBS) score of 21/56 or greater.
  • Patients that score below 21 or are non-ambulatory will not be considered for this study.
  • Patients that are emergently re-admitted to acute care and subsequently re-admitted to the stroke rehabilitation program will be reassessed for appropriateness of continuation in the study on a case by case basis.
  • Patients that progress to a BBS score of 21 or greater during their stay, and have a set discharge date of 10 days or longer, can be approached for study recruitment.
  • Appropriate cognition
  • Able to read and understand the consent, in English or a language available by translator services, based on the judgement of the clinical team, either by using outcomes measures, i.e. SLUMS greater than or equal to 20, or through clinical evaluations and team discussion. Eligibility will ultimately be decided by the treating physician in combination with the participant's clinical team.
  • Ability to tolerate and actively participate in up to six, 30-minute sessions, with physical therapy while using the BWSS.
  • Weigh less than 450 pounds, per the structural limitations of the ZeroG system.

You may not qualify if:

  • Active seizures
  • Spinal stabilization with the use of Halos
  • Uncontrolled hypertension or hypotension
  • Unstable skin structures (i.e. skin grafts)
  • Chest tubes
  • Unstable rib or lower extremity fractures
  • Severe osteoporosis
  • Participants where pressure around the abdomen, thighs, groin, or shoulders in contraindicated
  • Cognitive deficits that would disrupt the ability to provide informed consent as described above
  • Active enteric infection control precautions
  • Subjects would be eligible once precautions are lifted
  • Ongoing orthostasis
  • New limb amputations
  • Vestibular disorders that may impact balance
  • Premorbid conditions that may impact balance
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Gaylord Hospital

Wallingford, Connecticut, 06492, United States

Location

MedStar National Rehabilitation Hospital

Washington D.C., District of Columbia, 20010, United States

Location

Spaulding Rehabilitation Hospital

Sandwich, Massachusetts, 02537, United States

Location

Providence St. Luke's Rehabilitation Medical Center

Spokane, Washington, 99202, United States

Location

Related Publications (15)

  • Alguren B, Lundgren-Nilsson A, Sunnerhagen KS. Functioning of stroke survivors--A validation of the ICF core set for stroke in Sweden. Disabil Rehabil. 2010;32(7):551-9. doi: 10.3109/09638280903186335.

    PMID: 20136473BACKGROUND
  • Chen N, Xiao X, Hu H, Chen Y, Song R, Li L. Identify the Alteration of Balance Control and Risk of Falling in Stroke Survivors During Obstacle Crossing Based on Kinematic Analysis. Front Neurol. 2019 Jul 30;10:813. doi: 10.3389/fneur.2019.00813. eCollection 2019.

    PMID: 31417488BACKGROUND
  • Forster A, Young J. Incidence and consequences of falls due to stroke: a systematic inquiry. BMJ. 1995 Jul 8;311(6997):83-6. doi: 10.1136/bmj.311.6997.83.

    PMID: 7613406BACKGROUND
  • Esmaeili V, Juneau A, Dyer JO, Lamontagne A, Kairy D, Bouyer L, Duclos C. Intense and unpredictable perturbations during gait training improve dynamic balance abilities in chronic hemiparetic individuals: a randomized controlled pilot trial. J Neuroeng Rehabil. 2020 Jun 17;17(1):79. doi: 10.1186/s12984-020-00707-0.

    PMID: 32552850BACKGROUND
  • Mansfield A, Aqui A, Danells CJ, Knorr S, Centen A, DePaul VG, Schinkel-Ivy A, Brooks D, Inness EL, Mochizuki G. Does perturbation-based balance training prevent falls among individuals with chronic stroke? A randomised controlled trial. BMJ Open. 2018 Aug 17;8(8):e021510. doi: 10.1136/bmjopen-2018-021510.

    PMID: 30121600BACKGROUND
  • Kang H. The prevention and handling of the missing data. Korean J Anesthesiol. 2013 May;64(5):402-6. doi: 10.4097/kjae.2013.64.5.402. Epub 2013 May 24.

    PMID: 23741561BACKGROUND
  • Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. No abstract available. Erratum In: Circulation. 2017 Mar 7;135(10):e646. doi: 10.1161/CIR.0000000000000491. Circulation. 2017 Sep 5;136(10):e196. doi: 10.1161/CIR.0000000000000530.

    PMID: 28122885BACKGROUND
  • Landers MR, Oscar S, Sasaoka J, Vaughn K. Balance Confidence and Fear of Falling Avoidance Behavior Are Most Predictive of Falling in Older Adults: Prospective Analysis. Phys Ther. 2016 Apr;96(4):433-42. doi: 10.2522/ptj.20150184. Epub 2015 Aug 20.

    PMID: 26294679BACKGROUND
  • Legters K. Fear of falling. Phys Ther. 2002 Mar;82(3):264-72. No abstract available.

    PMID: 11869155BACKGROUND
  • Hidler J, Hamm LF, Lichy A, Groah SL. Automating activity-based interventions: the role of robotics. J Rehabil Res Dev. 2008;45(2):337-44. doi: 10.1682/jrrd.2007.01.0020.

    PMID: 18566951BACKGROUND
  • Chien JE, Hsu WL. Effects of Dynamic Perturbation-Based Training on Balance Control of Community-Dwelling Older Adults. Sci Rep. 2018 Nov 22;8(1):17231. doi: 10.1038/s41598-018-35644-5.

    PMID: 30467355BACKGROUND
  • Shimada H, Obuchi S, Furuna T, Suzuki T. New intervention program for preventing falls among frail elderly people: the effects of perturbed walking exercise using a bilateral separated treadmill. Am J Phys Med Rehabil. 2004 Jul;83(7):493-9. doi: 10.1097/01.phm.0000130025.54168.91.

    PMID: 15213472BACKGROUND
  • Steib S, Klamroth S, Gassner H, Pasluosta C, Eskofier B, Winkler J, Klucken J, Pfeifer K. Perturbation During Treadmill Training Improves Dynamic Balance and Gait in Parkinson's Disease: A Single-Blind Randomized Controlled Pilot Trial. Neurorehabil Neural Repair. 2017 Aug;31(8):758-768. doi: 10.1177/1545968317721976. Epub 2017 Jul 31.

    PMID: 28758519BACKGROUND
  • Schinkel-Ivy A, Huntley AH, Aqui A, Mansfield A. Does Perturbation-Based Balance Training Improve Control of Reactive Stepping in Individuals with Chronic Stroke? J Stroke Cerebrovasc Dis. 2019 Apr;28(4):935-943. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.011. Epub 2019 Jan 7.

    PMID: 30630753BACKGROUND
  • Meyer A, Hrdlicka HC, Cutler E, Hellstrand J, Meise E, Rudolf K, Grevelding P, Nankin M. A Novel Body Weight-Supported Postural Perturbation Module for Gait and Balance Rehabilitation After Stroke: Preliminary Evaluation Study. JMIR Rehabil Assist Technol. 2022 Mar 1;9(1):e31504. doi: 10.2196/31504.

    PMID: 35080495BACKGROUND

Related Links

MeSH Terms

Conditions

StrokeGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
John Corbett
Organization
Gaylord Specialty Healthcare

Study Officials

  • Pete Grevelding, MSPT

    Gaylord Hospital, Inc

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, subjects and investigators will not be able to be masked to the intervention. The assessor will not be able to be masked to group assignments, as the presence or absence of certain variables in the dataset, namely the perturbation level, will immediately reveal group assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This will be a multisite, randomized, active-comparator controlled clinical trial.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2021

First Posted

November 5, 2021

Study Start

December 15, 2021

Primary Completion

November 6, 2023

Study Completion

November 6, 2023

Last Updated

November 14, 2025

Results First Posted

April 8, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Copies of the study protocol will be provided upon request. Requests for copies of the de-identified research data will be considered on a situational basis after the final analysis has been completed. To make such a request please contact Dr. Henry C Hrdlicka (hhrdlicka@gaylord.org).

Locations